MedTech startups found themselves flush with cash a couple of years ago for quite obvious reasons. Pandemic-fuelled investment pushed VC funding for medtech and health-focused companies to unforeseen heights. But times have certainly changed. The medical device industry now finds itself reckoning from the banking crisis and VCs shifting priorities (and funds) towards other opportunities. That shift has caused funding for early-stage medtech companies to decline significantly, with numbers sliding by the billions across the board for digital health projects. Entrepreneurs and developers in MedTech will have to shift their focus on projects that either address the most common pain points in healthcare or projects that bridge different industries to create innovative healthcare solutions. What are the best strategies to do this during times like these?
Today's guest is the CEO of Single Pass, Bill Colone. He is an experienced medical device executive with expertise in investor presentations, fund raising, building teams, product development, operations management, Class II and Class III Medical Device clinical trials, start-up organizations, and hands-on experience with peripheral cardiovascular devices from concept through commercialization. He is a seasoned entrepreneur, and MedTech executive who has held past roles as General Partner of Quantum Fund, CEO of Spinal Singularity, VP of R&D at Direct Flow Medical, Director of R&D at Endologix, and President and CEO of Arizona Heart Innovative Technologies. Join us for a lively discussion on the life lessons he's learned as a MedTech entrepreneur, the most important aspects of creating a start-up team, the best strategies for emerging MedTech companies in challenging economic times, and what Orange County needs to do to become a global medical device leader.
